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ABSTRACT
Alterations in the balance of mRNA and microRNA
(miRNA) expression profiles contribute to the onset
and development of colorectal cancer. The regula-
tory functions of individual miRNA-gene pairs are
widely acknowledged, but group effects are largely
unexplored. We performed an integrative analysis
of mRNA–miRNA and miRNA–miRNA interactions
using high-throughput mRNA and miRNA expres-
sion profiles obtained from matched specimens of
human colorectal cancer tissue and adjacent non-
tumorous mucosa. This investigation resulted in a
hypernetwork-based model, whose functional back-
bone was fulfilled by tight micro-societies of miR-
NAs. These proved to modulate several genes that
are known to control a set of significantly enriched
cancer-enhancer and cancer-protection biological
processes, and that an array of upstream regulatory
analyses demonstrated to be dependent on miR-145,
a cell cycle and MAPK signaling cascade master reg-
ulator. In conclusion, we reveal miRNA-gene clusters
and gene families with close functional relationships
and highlight the role of miR-145 as potent upstream
regulator of a complex RNA–RNA crosstalk, which
mechanistically modulates several signaling path-
ways and regulatory circuits that when deranged are
relevant to the changes occurring in colorectal car-
cinogenesis.
INTRODUCTION
An important paradigm of RNA–RNA interaction is oper-
ated by a class of small non-coding RNAs called microR-
NAs (miRNAs or miRs), which are involved in the post-
transcriptional regulation of RNA transcripts, by base-
pairing to partially complementary sites on the target mes-
senger RNAs (mRNAs), usually in the 3′ untranslated re-
gion (3′ UTR). Each miRNA has the potential to target
many genes, with many miRNAs able to synergistically reg-
ulate the same mRNA transcript (1,2).
Alterations in non-coding transcripts may play impor-
tant roles in cancer pathogenesis. Numerous miRNA-
encoding genes are frequently located at fragile genomic
sites or within regions frequently deleted or amplified in
neoplastic diseases (3). Deletion, mutation or methylation
of miRNA-encoding genes may cause deregulated expres-
sion of critical miRNAs, which can then act as oncomiRs
or tumour suppressors (4).
The main hallmark of colorectal carcinogenesis is the ac-
cumulation of genetic alterations in oncogenes and tumour
suppressor genes, which control crucial cellular processes
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such as proliferation, differentiation and apoptosis in the
colorectal epithelium (5). The first group of genetic alter-
ations includes inducers of chromosomal instability, which
is driven by amplifications/deletions of whole or subsec-
tions of chromosomes that can underlie both the progres-
sive inactivation of tumour suppressor genes, such as ade-
nomatous polyposis coli (APC), deleted in colorectal can-
cer SMAD4 and TP53, and the activation of oncogenes
such as KRAS (6,7). The second group of genetic alter-
ations induces microsatellite instability (MSI), which is as-
sociated with mutations in genes containing simple repeats,
such as those encoding the epidermal growth factor recep-
tor (EGFR), the apoptotic factor BCL2-associated X pro-
tein (BAX) and the transforming growth factor  receptor
II (TGFBR2). MSI results in the inactivation of genes be-
longing to the DNAmismatch repair family (8,9). The third
group of genetic alterations includes epigenetic alterations,
which together make the so said CpG island methylator
phenotype (CIMP). CIMP is characterized by epigenetic
instability and by high methylation levels of the promot-
ers of some tumour suppressor genes, such as the Cyclin-
Dependent Kinase Inhibitor 2A (CDKN2/p16), insulin-like
growth factor 2 (IGF2) andMLH1 (10).
All these events impact several key signaling pathways
that are commonly deregulated in carcinogenesis, includ-
ing WNT--catenin, EGFR, mitogen-activated protein ki-
nase (MAPK), TGF- and phosphatidylinositol 3-kinase
(PI3K). Alterations in the WNT--catenin pathway are re-
sponsible for many epithelial tumours, being involved in ap-
proximately 30–70% of human sporadic colorectal cancers
(CRCs). Mutations in the APC gene, affecting the carboxy-
terminal region, are implicated in -Catenin and axin bind-
ing, leading to the deregulated nuclear translocation of the
-catenin transcription factor from the cytoplasm (11). This
induces the genesis of a tumour phenotype by enhancing the
transcription of a number of oncogenes and target genes,
such as MYC and CCND1 (12). Sporadic CRCs, negative
for APC or CTNNB1 gene mutations, are characterized by
activation of the WNT signaling pathway via APC inhibi-
tion by miR-135, which, in turn, is upregulated in CRC, or
by direct modulation of -catenin by miR-200a, which al-
ternatively interacts with the 3’ UTR of CTNNB1 or drives
the down-regulation of the ZEB1/2 gene (13). EGFR is an
important player in colorectal carcinogenesis, being a mod-
ulator of critical cellular processes such as proliferation,
adhesion and migration. The EGFR intracellular signal
transduction pathways include components of the MAPK,
PI3K, signal transducer and activator of transcription, pro-
tein kinase C and phospholipase D pathways. In particu-
lar, the MAPK pathway modulates numerous key kinases,
which, in turn, control cell growth, differentiation, prolifer-
ation, apoptosis and migration through a series of interme-
diate proteins, includingRAF,MEK andRAS (14). The lat-
ter is a critical gene, since it can unleash its signaling cascade
either by PI3K, thereby inhibiting apoptosis, or by RAF,
thereby stimulating cellular proliferation. The anomalous
activation of the receptor tyrosine kinases or the gain-of-
function mutations occurring in the RAS or RAF genes are
reported to cause the deregulation of the RAS-RAF-MEK-
ERK-MAPK axis, which, in turn, is a frequent therapeutic
target (15–17). Interestingly, the down-regulation of miR-
143 was shown to contribute to ERK/MAPK activation, as
well as to KRAS and ERK5 repression (18).
CRC onset and progression are related to a combination
of causal perturbations occurring at any omics layer (19)
and relevant studies have brought out the anomalous inter-
actions between gene transcripts and miRNA molecules as
crucial causes of carcinogenesis (20–24). In exactly this di-
rection, this work aims at scrutinizing the mRNA–miRNA
crosstalks in search of mutual and combined effects on the
whole colorectal carcinogenesis process. It borrowed com-
putational and analytical methods from Systems Biology
to inspect both transcriptome layers and their interactions,
and to look for socially central (groups of) molecules. We
addressed this issue by a multifaceted analysis strategy, en-
compassing a series of functional enrichment, topological
and clustering analyses, which were conducted on genome-
wide mRNA and miRNA expression profiles of matched
pairs of tumour and adjacent non-tumorous mucosa sam-
ples obtained from CRC patients. In silico analyses high-
lighted the prominent topological position of miRNA-145,
and its mechanistic role in maintaining cohesiveness and
functional cooperation among groups of key miRNAs and
genes. Given the critical tumour suppressive role of miR-
145, its action, combined with several other miRs, was
deemed responsible for a coordinated program of patterned
gene regulation, whose master regulator was actually miR-
145. The discovery of its partners and of the unexplored ef-
fects of their interactions in colorectal carcinogenesis was,
therefore, a further objective of this work. This was achieved
by first identifying in silico the co-expressing partners of
miR-145, and then, by perturbing them in vitro in four CRC
cell lines.We verified that the ectopic expression of miR-145
impacts the whole miRNA network and that, downstream,
this perturbs the MAPK signaling cascade.
MATERIALS AND METHODS
Data sources
The datasets analysed in this study consisted of the tran-
scriptome (25) and miRNAome (20) of a set of 14 matched
pairs of tumour and adjacent non-tumorous mucosa sam-
ples obtained from CRC patients and evaluated with the
GeneChip Human Exon 1.0 ST array and GeneChip
miRNA 2.0 array (Affymetrix, Santa Clara, CA, USA).
Statistical analysis
Expression data analyses were performed usingGNURver.
3.0.2 (http://www.r-project.org/) and the Partek Genomics
Suite package ver. 6.6 (Partek, St. Louis, MO, USA). Low-
level analysis and normalization were done using GCRMA
(26) and Partek. We filtered the probe sets and kept only
those present in at least six samples. To reduce noise, we
also removed probe sets that do not map to an Entrez gene.
Batch effects were removed by the Partek’s batch effect re-
moval algorithm. The resulting genes and miRs were tested
for differential expression, using the paired t-statistics. Un-
der the assumption of equal variance between groups, al-
lowing a number of false positives equals to 2% of the
genome and setting the minimum log2 fold change (log2
FC) expression barriers to ±1.5, we achieved a statistical
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power of 0.8. Correlations between miRNA expression val-
ues were estimated using the Spearman’s rank correlation
coefficient (rs) using Rcmdr (27). (i) The relationships be-
tween miR-145 and its direct and indirect partners were as-
certained by regression analysis. Time-to-event analysis was
performed by the Mantel-Haenszel test and the 50% per-
centiles of miRNAs were used to dichotomize patients into
low and high expression groups. Kaplan–Meier curves were
drawn for CRC patients taken from The Cancer Genome
Atlas (TCGA) dataset (https://tcga-data.nci.nih.gov/tcga/
tcgaHome2.jsp). A P-value <0.05 was considered statisti-
cally significant. Equality of proportion was assessed by
Chi-squared test.
Gene selection strategy and in silico functional and pathway
analyses
To make results more reliable, only differentially expressed
genes deregulated in at least five CRC-related experiments
retrieved from Gene Expression Atlas (28) were selected.
These underwent functional enrichment analysis against
the Gene Ontology FAT sub-set and the set of genes
with probe sets included in the used Affymetrix chips. Re-
sults obtained with DAVID (29) web services were cross-
checked with Babelomics (30) and considered for inclusion
if Bonferroni-corrected significance levels did not exceed
5%. General functional classes were refined by a mixture
test between the elim and weight algorithms (31). These de-
termined the best enrichment in a bottom-up order, by pro-
gressively removing genes from functional classes, which
were enriched by more specific categories. This analytical
procedure facilitated the identification of specific cancer-
favorable and cancer-protection processes, with statistical
confidence. Pathways were detected by ToppGene (32),
where the hypergeometric distribution with False Discovery
Rate (FDR) correctionwas used as the standardmethod for
determining statistical significance. The P-value cut-off was
set to 0.05, while the gene limits ranged from 1 to 1500.
MiRNA selection strategy
We obtained a list of miRs that are reliably associated with
CRC by intersecting the set of miRs reported by miRSys-
tem (33) to target the genes selected in the previous analyt-
ical steps with that of miRs associated to CRC, according
to the Human microRNA disease Database (HMDD) (34).
MiRSystem is a database that integrates seven well-known
target gene prediction programs: DIANA, miRanda, miR-
Bridge, PicTar, PITA, rna22 and TargetScan. The observed
identification probability (O) for a given gene is the propor-
tion of the queried miRNAs predicted to target that gene,
whereas the expected probability (E) is the proportion of
all miRNAs in the miRSystem database predicted to tar-
get that gene, i.e. the number of target gene-miRNA pairs
deposited in the miRSystem database. This expected proba-
bility represents the chance of one gene being randomly se-
lected by miRNAs. We only considered experimentally val-
idated targets, with an O/E ratio greater than 1.5.
Networks analysis
We obtained hypergraphs connecting genes by querying a
number of heterogeneous data sources: (i) Interpro and
PFAM, (ii) Gene Expression Omnibus, (iii) BIOGRID
and IREF, (iv) PathwayCommons, IMID, NCI-NATURE,
REACTOME, KEGG, BIOCARTA and (v) BIOGRID,
BIND, HPRD, INTACT, MINT, MPPI, OPHID, through
GeneMANIA (35). We linked any two genes by an undi-
rected edge, whenever an evidence of interaction was found,
which we weighted with a value provided by GeneMANIA
that indicates the predictive power of the selected dataset
for that edge (35). Several pairs of genes could be connected
by more than one edge. In such case, we agglomerated the
weights of multiple edges by the injective function
WAB = e
n
n
∑n
i=1 WABi ,
where n is the number of edges connecting any two nodes
A and B, and i refers to the ith edge. WABi stands for the
weight of the ith edge. The multiplicative factor e
n
n is meant
to give increasing importance to multiple links in respect
to isolated links (36). We then built weighted graphs with
weights over the edges (carrying the reliability of the corre-
sponding interactions).
MiRNAs were given in input to Ingenuity Pathway Anal-
ysis (IPA), which wired a relevant network based on exten-
sive records maintained in the Ingenuity Pathways Knowl-
edge Base. This knowledge base has been abstracted into a
large network, called the Global Molecular Network, com-
posed of thousands of molecules that interact with each
other. Two molecules (miRNAs and genes here) are con-
nected if there is a path in the network between them. Inter-
actions can be physical and functional. We considered only
physical interactions and cancer-related functions, to build
a literature-based network. Dashed edges stand for indirect
relationships between molecules, i.e. they summarize paths
longer than one step.
The same set of miRNAs was filtered to contain only
those that were differentially expressed between our CRC
and control tissues as well as those that exhibited any signifi-
cant correlation of expression with at least another miRNA
(P-value < 0.05, rs > 0.4 or rs < −0.4). The resulting miR-
NAs were linked with non-oriented edges, since correlation
is a symmetric measure, and weighted using the Spearman’s
rank correlation coefficient (rs), to make an experimental
network (20).
Topological analysis
Genes and miRNAs were assigned a topological impor-
tance. All the considered metrics were based on the enumer-
ation of links (or shortest paths). Considering a path from s
∈ V to t ∈ V, with V the set of nodes, as an alternating se-
quence of nodes and edges beginningwith s and endingwith
t, such that each edge connects its preceding with its suc-
ceeding node, we calculated the length of a path by summing
the inverse weights of its edges. The idea is that highly corre-
lated miRNAs or functionally closest genes minimize their
distance. We calculated degree, betweenness, closeness, radi-
ality and clustering coefficient centrality indices, and ranked
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miRNAs and genes accordingly. Definitions of these indices
have been detailed previously (20).
Privileged topological position of miRs were inferred by
a combination of the IPA’s tools: BioProfiler and Upstream
Regulatory Analysis. These allowed inferring both which
miRNAs might have been up- or down-regulated in the ex-
periment and which one might be causally relevant. Acti-
vation z-scores were conservatively kept to a minimum of
±2.
Networks were drawn and analysed both by a custom
standalone tool, written in C# and usingNodeXL 1.0.1.332
(37), and by Cytoscape 3.0 (38).
Strongly connected components
Functional affinities of genes and miRNAs were sought
among highly cohesive groups of genes and miRNAs. To
this end, we used the Cluster ONE algorithm (39). It han-
dles weighted graphs and generates overlapping clusters. It
starts from a single node and greedily adds or removes new
nodes, if they alter the cohesiveness of the group. Subgroups
of less than five nodes or having a density less than a given
threshold (set at 3) were discarded. Finally, redundant co-
hesive subgroups were merged to form larger subgroups to
make the results easier to interpret.
MiRNAome and MAPK signaling pathway profiling after
miR-145 transfection in colon cancer cell lines
To identify any functional synergistic pairs of miRNAs,
the global miRNA expression profile was obtained in the
transfected colon cancer cell lines, as previously reported
(20). Briefly, CaCo2, SW480, HCT116 and HT-29 cell
lines were transiently transfected using HiPerfect Transfec-
tion Reagent (QIAGEN), with synthetic miR-145 mimic
(MSY0000437,QIAGEN), following themanufacturer’s in-
structions, as previously described (40). The total RNAwas
purified using the RNeasy kit (QIAGEN) and labelled us-
ing the 3DNA Array Detection FlashTagTM RNA Label-
ing Kit (www.genisphere.com). Samples were hybridized on
Gene-Chip miRNA Array (www.affymetrix.com), washed
and scanned with an Affymetrix Scanner. MiRNA expres-
sion data were then processed and analysed using the Ro-
bust Multi-array Average algorithm, and deposited in the
EMBL-EBI Array Express.
To assess the effect exerted bymiR-145 on theMAPKsig-
naling pathway, gene expression levels of the transfected cell
lines were quantified by using RT2 MAP Kinase Signaling
Pathway PCR Arrays (SABiosciences). Briefly, mRNA and
cDNA were prepared using reagents and equipment from
QIAGEN (QIAGEN Hamburg, Germany) and assayed
with the RT2 MAP Kinase Signaling Pathway PCR Ar-
rays (SABiosciences) with SABiosciences RT2 qPCR Mas-
ter Mix according to the manufacturer’s instructions. Plates
were read on 7900 TaqMan (Applied BioSystem, Life Tech-
nologies Corporation) with 1 cycle of 10 min at 95◦C fol-
lowed by 45 cycles of 15 s at 95◦C and 1 min at 60◦C. SYBR
Green fluorescence was monitored at the annealing step of
each cycle and analysed with SDS v.2.4 software (Applied
BioSystem, Life Technologies Corporation). The analysis
of the gene expression was completed using the SA Bio-
sciences PCR Array Data Analysis Web Portal, as recom-
mended by the manufacturer, and verified using the Ct
method.
RESULTS
From biological processes to gene regulatory networks
A total of 4.441 genes were significantly deregulated be-
tween matched tumour and adjacent non-tumorous tissues
(2.549 up-regulated and 1.892 down-regulated in the CRC
specimens), of which 1.645 and 878, respectively, main-
tained the same expression direction in at least five ex-
periments deposited in the EBI Gene Expression ATLAS.
As a proof of concept, we verified that the CRC path-
way (hsa05210 KEGG pathway, Figure 1) was significantly
impacted. Twenty-eight out of 45 genes of this pathway
were deregulated in a statistically significant way (p=1.32E-
10). These genes are known to functionally participate to
four macro biological processes (BPs): proliferation, (anti)-
apoptosis, growth and cell cycle control.
Through functional enrichment analysis, 2.091 genes
(83% of the whole genes set) significantly associated to at
least one of these BPs, compared to 9.089 genes (52.1%
of the background set of genes) known to carry out these
processes (P < 0.0001). Based on the log-Odds ratios
and the class of BPs, the resulting BPs were classified as
cancer-favorable (Adj p =0.016) or cancer-protection (Adj
p =0.0012), according to whether they were positively or
negatively associated to the colorectal carcinogenesis pro-
cess or, more generally, to cancer-related processes (Adj P
< 0.001) (Supplementary Table S1). In particular, cancer-
favorable processes included 48 genes hampering apoptosis,
23 genes promoting cell cycle progression, 92 genes increas-
ing proliferation and 9 genes promoting cell growth. On the
other hand, we counted 106 apoptosis-favorable genes, 53
genes promoting cell cycle control, 95 genes hindering pro-
liferation and 24 genes decreasing cell growth. The remain-
ing genes fell in the cancer-related set of BPs, 158 of which
were apoptosis-associated, 105 involved in cell cycle regula-
tion, 199 were proliferation modulators and 42 were related
to cell growth. We selected 391 genes (Supplementary File
S1).
We submitted the whole set of 391 genes to GeneMA-
NIA in order to reconstruct their interaction network. Pairs
of genes were linked if they shared at least one experimen-
tally verified relationship. The resulting network exhibited
relationships of co-expression (52.65% of the total number
of relationships), co-localization (14.85%), physical interac-
tions (13.52%), shared pathways (9.06%), shared predicted
interactions (8.44%), shared genetic interactions (1.23%)
and shared protein domains (0.26%). Technically, this net-
work comes as a hypergraph, since it allows more than one
edge connecting two nodes. The network was reduced to a
graph, as described in the ‘Materials andMethods’ section.
The resulting network is made of one connected compo-
nent, with mild cohesiveness: clustering coefficient = 0.257,
diameter = 4 and network density = 0.095. As generally
defined, network density ranges from 0 to 1, and measures
how densely a network is populated with edges. A network
with no edges and solely isolated nodes has a density equal
to 0 (cf. Supplementary File S2 for gene-wise topological
D
ow
nloaded from
 https://academ
ic.oup.com
/nar/article-abstract/44/9/4025/2462423 by guest on 03 D
ecem
ber 2018
Nucleic Acids Research, 2016, Vol. 44, No. 9 4029
nucleus
MSI pathway only
MSI pathway only
DNA
DNA
DNA
DNA
DNA
Loss of growth inhibitory
effects of TGFb
Karyotipic instability
impaired G1 cycle arrest
reduced apoptosis
Suppressed apoptosis
Suppressed apoptosis
TGF-beta signaling
pathway
Suppressed apoptosis
Wnt signaling pathway
PI3K-Akt signaling
pathway
Proliferation
Survival
Proliferation
p53 signaling pathway
MAPK signaling
pathway
beta-catenin
APC
DNA damage
c-Myc
Cyclin d1
Cyclin-D1
beta-catenin
TCF/LEF
BIRC5
Apoptosis
Cell cycle
Apoptosis
TGFbeta-RII
TGFBR1
TGFbeta-RII
Colorectal cancer
SMAD4
hMSH2
PKB/Akt
BCL2
AXIN
K-RAS
PI3K
hMSH6
GSK3B
APC
BAX
c-Myc
TP53
BAD
Cyt c
CASP3
TGFB1
JNK
CASP9
CASP9
hMSH3
hMLH1
APPL1
Rac/Rho
ERKRAF
RALGDS
DCC
SMAD2/3
C-FOS
CASP3
c-Jun
MEK
Defective apoptosis
mitochondrion
GSK3B
AXIN
SOS2
MET
FZD3/6
DVL1/3
Figure 1. Genes involved in CRC pathway. Up-regulated (red) and down-regulated genes (blue) of the CRC pathway (KEGG id: hsa05210). TCF7 and
LEF1 glyphs are condensed in TCF/LEF; PIK3R2, PIK3CG, PIK3CD in PI3K and MAPK10 in JNK, being JNK3 one of its synonyms. As to PI3K
bicolour representation, PIK3R2, was up-regulated, while PIK3CG and PIK3CD were down-regulated in tumour tissues.
scores). The network decomposition procedure identified 11
modules (Figure 2, Supplementary Table S2), classified and
divided into two cancer-protection and nine cancer-favorable
modules, according to the BPs which their genes partici-
pate in, and as to whether their genes are up-regulated or
down-regulated (Supplementary Table S2). In Supplemen-
tary File S2, we report a list of the most central genes, also
known as intramodular hubs, which includes TP53 (module
6),MYC (module 10), CDK4 (module 2), CTNNB1 (mod-
ule 4), CHEK1 and CDK2 (module 1). These were the top
six genes, in terms of centrality, for at least three out of
the four above-mentioned topology indices. Intramodular
hubs link to several proteins that are highly self-connected
and that are, therefore, more likely to perform any biolog-
ical task in cooperation (41). Such hubs are almost never
pleiotropic.
Functional modules in literature-based and experimental
miRNA networks
We have retrieved 41 experimentally verified miRNAs
(cf. Supplementary Table S4) targeting the 391 above-
mentioned genes by miRSystem and selected only those
that were reported by the HMDD to be associated to
CRC. These were given in input to IPA that wired a
literature-based network of 19 of these miRNAs, together
with 19 miRNA-controlled genes (Figure 3A). As antici-
pated, edges among molecules were drawn only if they rep-
resented physical interactions or evidence of participation
to the same cancer-related biological functions.
An experimental network was derived from the 41 above-
mentioned miRNAs. A miRNA was selected to populate
the network only if it was differentially expressed between
tumour and adjacent non-tumorous tissues and signifi-
cantly correlated with at least a miRNA within the net-
work. Thirty-nine out of 41 miRNAs were linked by 148
edges (Figure 3B).Missed miRNAs in the experimental and
literature-based networks are reported in Supplementary
Table S4. In particular, the latter network contained miR-
335, which was missing in the former. Generally, the exper-
imental network almost included the other network. As for
the relationships between miRNAs, the two networks did
not properly match, indicating that there is room for devel-
oping plausible new functional relationships between miR-
NAs involved in CRC development.
Topological analysis of the experimental network indi-
cated two significant clusters: a triangle made of miR-708,
miR-18b and miR-17 and a clique made of miR-144, miR-
1246, miR-1275 and miR-99a. Both modules were made of
nodes not present in the literature-based network, but miR-
17. MiR-17 and miR-1246 or miR-99a were used as seed-
ing nodes by Cluster ONE for the detection of the modules.
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Figure 2. Networks clustering. Nodes represent genes that are connected by undirected edges. Genes may be connected by multiple edges, in cases where
more than one functional evidence of interaction exists between them.
D
ow
nloaded from
 https://academ
ic.oup.com
/nar/article-abstract/44/9/4025/2462423 by guest on 03 D
ecem
ber 2018
Nucleic Acids Research, 2016, Vol. 44, No. 9 4031
A B
Figure 3. Literature-based and experimental networks of miRNA interactions. (A) Literature-based network: two miRNAs are connected if there is any
evidence of physical or (cancer-related) functional interactions. (B) Experimental network: it connects any two miRNAs if they are differentially expressed
between matched pairs of tumour and adjacent non-tumourous mucosa samples, and if their expression values are statistically correlated. Colours indicate
miRNA clusters. Coloured labels specify miRNAs that are topologically important. Red lines join miRNAs making a triangle and a clique.
Figure 4. MiRNAs–mRNAs intermodular hubs. The triangle made of
miR-708, miR-18b, miR-17 and the clique made of miR-144, miR-1246,
miR-1275, miR-99 interact with four intermodular hubs, i.e. TP53, CDK2,
CDK4 andMYC.
Among these, miR-708,miR-18a, miR-18b andmiR-17, to-
gether with miR-92b, miR-10b and let-7e were the most im-
portant miRNAs of the network, from a positional perspec-
tive (cf. Supplementary File S3). These miRNAs control
four of six intramodular hubs, namely TP53, MYC, CDK4
and CDK2 (cf. Supplementary File S2), which, in this con-
text, can be considered as intermodular hubs, as they connect
the two modules (Figure 4). It is worth noting that inter-
modular hubs are usually pleiotropic and connect to differ-
ent biological modules, interacting with different partners
at different moments and/or within different cellular com-
partments. As seen in Supplementary Table S3, these miR-
NAs also control the top five genes in terms of O/E scores:
CCNA2 (module 1),MYC (module 10), LRP5 (module 8),
E2F1 (module 1),HSPA8 (module 3), from the initial list of
391 genes.
Leading topological position of miRNA-145 in upholding co-
hesiveness and functional cooperation among groups
Upstream analysis of intra/intermodular hub genes re-
vealed a prominent mechanistic and topological position of
miR-145 (z-score = 2.35), miR-9 (z-score 2.11) and miR-
137 (z-score = 2.07). Of these, miR-145 was the only differ-
entially expressed miRNA in our experiment.
The hypothesis that miR-145 could be a master regulator
of the CRC network was sustained both statistically, by the
experimental network, and functionally, by the literature-
based network. MiR-145 was strongly correlated with most
of the aforesaid miRNAs (see Figure 3B). The analysis of
gene expression profiles of CRC patients available through
the TCGAdatabank not only confirmed that the expression
of miR-145 correlates with that of miR-17, miR-23b and
miR-99a (one of the seeding nodes) but also that these were
likely to be causally dependent on miR-145 (P < 0.0001).
Additionally, high expression values of let-7e and miR-92b
resulted moderate risk factors, if coupled with high expres-
sion values of miR-145. Similarly, low profiles of let-7e and
miR-92b conferred a worse prognosis, if coupled with low
expression values of miR-145. High values of miR-10b and
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miR-143, instead, were risk factors if concomitant with low
values of miR-145 (Supplementary File S6).
More generally, miR-145 resulted to be directly con-
nected with several components of important clusters
of miRNAs, which in turn targeted relevant intra/inter-
modular hub genes, as reported in Supplementary Table S3.
Topologically, miR-145 was linked through miR-93 to the
triangle made of miR-708, miR-18b and miR-17 and to the
clique made of miR-144, miR-1246, miR-1275 and miR-
99a, thereby controlling, even indirectly, four intramodular
hubs, namely TP53, MYC, CDK4 and CDK2 (Supplemen-
tary File S2).
With no intention of discussing the renowned direct im-
plication of miR-145 deregulation in colorectal carcinogen-
esis, well aware thatmolecular competition represents a uni-
versal and frequent form of gene regulation that operates
also in RNA regulatory networks, and as a consequence of
the above results, we focused on the short-range interactions
of miR-145 with the aim to highlight its apical regulative
role on key genes and biological functions related to CRC
development.
Effects of the ectopic expression of miR-145 in CRC cell lines
The effect of the ectopic expression ofmiR-145 on 866miR-
NAs was assessed in four human colon cancer cell lines.
Only miRNAs showing statistically significant differential
expression (P < 0.05, log2 FC ≥ 1.5, log2 FC ≤−1.5) af-
ter miR-145 ectopic expression were considered (see Sup-
plementary File S4). Several miRNAs were differentially
expressed in the four tested cell lines: 82 miRNAs in the
CaCo2 cell line (32 up-regulated and 50 down-regulated),
120 miRNAs in HT-29 cells (58 up-regulated and 62 down-
regulated), 90 miRNAs in HCT116 cells (49 up-regulated
and 41 down-regulated) and 95 miRNAs in the SW480 cell
line (58 up-regulated and 37 down-regulated). Among these,
three direct partners of miR-145 were modulated in three
of four cell lines. In particular, miR-99a was highly down-
regulated in CaCo2 cells (p= 0.036, log2 FC=−4.36), miR-
23b was mildly down-regulated in the HT29 cell line (p =
0.004, log2 FC =−1.81), and miR-143 was up-regulated in
SW480 cells (p = 0.046, log2 FC =1.52). Moreover, among
the deregulated miRNAs, we found at least one miRNA,
for each cell line, that was indirectly connected to the miR-
145: miR-23a (p =0.004, log2 FC =−5.14) in CaCo2 cells;
miR-23a (p =0.008, log2 FC =−1.84) and miR-27a (p
=0.039, log2 FC =−2.5) in HT29 cell, with both included
in miR23a∼miR27a∼miR24-2 cluster, and being down-
regulated; miR-18a* (p = 0.002, log2 FC = 2.32), included
in the miR17∼miR92a cluster, and miR-24-1* (P < 0.001,
log2 FC =2.4), included in miR23b∼miR27b∼miR3074
cluster, were up-regulated in SW480 cells. MiR-1246 was
also up-regulated in HCT-116 cells (p = 0.041, log2 FC =
3.47) and mildly in HT29 cells (p = 0.038, log2 FC = 1.32).
All direct and indirect targets of miR-145 that resulted
from our in silico analysis, other than enriching several cell-
cycle related processes, did significantly enrich two impor-
tant pathways: the PI3K pathway through FGF3, FRAP1
and RPTOR (p = 0.000049), the WNT signaling path-
way through FZD5, FZD8 and PPP3CA (p = 0.00039),
and the MAPK signaling pathway through CRK, FAS,
MAP3K5, MAP3K8, MAPK14, RAPGEF2, RPS6KA5,
TGFBR2, CHUK, DUSP5, MAP4K3, PDGFA, RRAS2,
DUSP8, FGF4, HSPA8, FGFR3, FRAP1 and PPP3CA
genes (p = 0.0289).
MAPK signaling pathway is modulated by miR-145 ectopic
expression in CRC cell lines
The main impact of miR-145 over-expression regarded the
expression of several genes participating to the MAPK sig-
naling pathway. Their expression profiles were compared
with those measured in untransfected cells, as well as in
matched tumorous and adjacent non-tumorous colon tis-
sues obtained from CRC patients (Figure 5).
In particular, CDKN2C greatly increased its expression
both in CaCo2 and in HT-29 cells (log2 FC = 3.43 and
4.46, respectively), while it was not differentially expressed
in the genome-wide profiling study. On the other hand,
MAP2K4 slightly increased its expression in both HCT116
and HT-29 cells (log2 FC =1.69 and 1.37, respectively),
whereas it was significantly down-regulated in the tumour
tissues (log2 FC =−2.87). A similar trend was observed in
HT29 cells for the following genes: CDKN1A, CDKN2B,
KRAS, PRDX6 andSMAD4.KRAS andSMAD4 that were
up-regulated after transfection (log2 FC =1.53 and 2.74,
respectively), but were down-regulated in our CRC spec-
imens (log2 FC =−2.63 and −3.1, respectively). Finally,
ELK1 and CDK2, which exhibited elevate closeness and de-
gree centrality scores, were both up-regulated in our CRC
specimens (log2 FC = 4.56 and 4.34, respectively). In con-
trast, ELK1 was down-regulated in HCT116 cells (log2 FC
=−4.64) and up-regulated in HT-29 cells (log2 FC = 1.93),
while CDK2 was imperceptibly down-regulated in SW480
cells (log2 FC =−1.17) and up-regulated in HT-29 cells
(log2 FC = 2.27), after miR-145 transfection (Figure 5 and
Supplementary File S5). Interestingly, HT29 cells showed
up-regulation of most of the MAPK pathway genes, with
the exception of CDKN1C, LAMTOR3 and RLPO.
These genes are not direct targets of miR-145, but of
miR23a, miR-23b, miR-26b, miR-99a and miR-18a (Sup-
plementary Table S5), which in turn, were deregulated in
the four cell lines, as an effect of the ectopic expression of
miR-145 (Supplementary File S4). In particular, we found
alterations of both miR-23a and miR-23b in HT-29 cells.
Being highly similar in their mature sequences, they are ex-
pected to control the same transcripts, which are known to
mostly belong to the KRAS and TGF signaling pathways,
andwhich, in our study, are those of theK-RAS, cMYC and
E2F1 genes, as reported in Figure 6.
DISCUSSION
Our integrative analysis of mRNA–miRNA and miRNA–
miRNA interactions identified two cancer-protection and
nine cancer-favorable modules of genes and provided in-
teresting mRNA–miRNA crosstalks. A number of genes
emerged that demonstrated a relevant dual role, both being
intramodular and intermodular hubs. A strongly connected
sub-network was made up, in fact, by TP53, MYC, CDK4,
CTNNB1, CHEK1 and CDK2, which were the most cen-
tral genes (some of the intramodular hubs). CDK4, CDK2
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Figure 5. Heatmap of the MAPK signaling pathway genes. Fold change
expression data of MAPK signaling pathway genes in four colon cancer
cell lines aftermiR-145 ectopic expression. For comparative purposes, gene
expression values of matched pairs of tumour and adjacent non-tumorous
mucosa samples are also shown.
and especially TP53 and MYC also acted as intermodular
hubs, because they connected two cohesive clusters, the one
made of miR-99a, miR-144 and miR-1275, for which miR-
1246 worked as seeding node, and the triangle made up of
miR-18b, miR-708 and miR-17, the latter being the seeding
node.
The expression level of miR-145 was highly correlated
with the above-mentioned clique and triangle and, directly
or indirectly, with miR-93, miR-143, miR-18a, miR-23a
and miR-23b, miR-31, miR-345, miR26b, miR-185 and
miR-20a, thus acting as potent modulator of four intramod-
ular hubs, namely TP53, MYC, CDK4 and CDK2I, and as
the genuine actuator of a number of important biological
functions and pathways (42–45).
First, miR-145 demonstrated to exert a certain control
on the cell cycle process through a series of partners: BCL2,
FAS, PPIF, MYC and E2F1. In particular,MYC promotes
the transcription and E2F1 binds to the promoter region
of the polycistronic cluster miR-17∼92 (also known as
oncomiR-1), one of themost potent oncogenic clusters, par-
ticipating to cell proliferation and apoptosis control (46–50).
In particular, miR-145 evidenced a significantly negative
causal influence on two of the six members of this cluster,
miR-17 and miR-18a. Concomitant lower expression val-
ues of miR-145 and miR-18a are prognostic evidences of
poor survival, by TCGA data analysis. Notice that E2F1
exhibits the highest clustering coefficient score, confirming
its high sociality in the whole network. Most of the compo-
nents of this cluster are directly linked to miR-145 (Figure
3B). The control on cell cycle-related processes by miR-145
is strengthened by its indirect modulation of the expression
ofmiR-21 (Figure 3B) and by the direct control ofCDC25A
and CDK6 genes (in particular this gene ranked 10th by the
closeness centrality measure).
Second, miR-145 ectopic expression in CRC cell lines
triggered the downstream deregulation of critical genes, a
significantly high number of which are closely related to
the MAPK signaling pathway. MYC is activated by vari-
ous mitogenic signals, such as WNT, SHH and EGF, via
the MAPK/ERK signaling pathway, and in our dataset it
was aberrantly expressed. Equally, ELK1, which is known
to induce the c-fos proto-oncogene upon phosphorylation
byMAPKs (47), was deregulated in our cell lines, being un-
der the control of miR-143, which in turn correlates with
miR-145.CDK2 regulates G1/S transition and S phase pro-
gression in association with cyclin E and A. Its activation
is dependent on its localization in the nucleus, which can
happen upon the formation of CDK2/MAP Kinase com-
plexes (48). MiR-145 has a double indirect influence on this
gene, via the MAPK signaling pathway and because of its
negative correlation with miR-18a, of whichCDK2 is a the-
oretical target. MAPKs are also known to modulate the
outcome of SMAD activation by TGF-. Cross-signaling
mechanisms between the SMADandMAPKpathways take
place and affect cell fate in the context of carcinogenesis
(49). MiR-145 exerts a double control even on SMAD4
(module 3), modulating the MAPKs and directly targeting
SMAD4.
Third, miR-145 was tightly connected with miR-143, in
line with the literature. They share numerous target genes
involved in various cancer-related events, with both influ-
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Figure 6. Downstream effects of miR-145 ectopic expression. Pathway map representing the experimental effect points of miR-145 ectopic expression in
the HT-29 cell line.
encing phenotypic patterns, as evidenced by experiments
entailing the concomitant ectopic expression of the miR-
143∼miR-145 polycistronic cluster in the HT-29, HCT116
and SW480 cell lines, and showing significant decrease in
proliferation, migration, anchorage-independent growth and
chemoresistance; these miRNAs can work independently
or synergistically, with an effect on the colon cancer tran-
scriptome and proteome being characterized by distinct
and shared functional effects (50–52). In particular, the
miR-143∼miR-145 polycistronic cluster targets the RAS-
responsive element-binding protein (RREB1) and KRAS
(53), which, in turn, induce down-regulation of the clus-
ter, thereby sustaining a feed-forward mechanism (54) that
could explain the concurrent down-regulation of KRAS
and miR-143∼miR-145 cluster in our CRC cohort. From
this study, it emerges that it is likely that miR-143 is an ef-
fector of miR-145, rather than being equal cooperators. By
the analysis of TCGA data comes out that the expression of
miR-143 is linearly dependent on miR-145 expression and
that the prognosis of patients with low levels of miR-145
and high levels of miR-143 is dismal.
In conclusion, the simultaneous evaluation of the tran-
scriptome andmiRNAome ofmatched pairs of tumour and
adjacent non-tumorous mucosa samples of CRC patients
helped identifying severalmodules of genes andmiRNAs.A
multifaceted enrichment analysis revealed that these mod-
ules can cooperate, rather compete, as micro-societies, in
the fulfilment of pathophysiological mechanisms underly-
ing the onset and development of CRC. Although several, if
not all, members of these clusters could potentially be con-
sidered good prognostic and therapeutic targets, many of
them, alone, proved to be globally ineffective in the treat-
ment of the disease. For this reason, the hunt for biomark-
ers shifts attention towards the master-regulators, i.e. the
molecules that, when pharmaceutically targeted, can plausi-
bly result in a maximal derangement and destabilization of
the core tumourmachinery.We focused onmiR-145, which,
following in silico and in vitro analysis, demonstrated a high
potential in this direction and could be reliably targeted for
diagnostic, prognostic and therapeutic purposes.
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